THURSDAY, Jan. 6, 2022 (HealthDay News) — A medication that acts on certain brain receptors can temporarily ease visual-processing problems in some adults with autism, a small study has found. Researchers said it’s far too early to know whether the drug, arbaclofen, could prove useful in managing those visual issues.Continue Reading

TUESDAY, Jan. 4, 2022 (HealthDay News) — Many insured cancer patients still experience serious money problems linked to their illness, new research affirms. For example, nearly 3 out of 4 insured patients with colon cancer have major financial hardship in the year after their diagnosis, which affects their social functioningContinue Reading

MONDAY, Jan. 3, 2022 (HealthDay News) — An international trial found that a once-a-day antiretroviral medication for kids with HIV is not only cheap and easy to take, but also better at suppressing HIV than standard treatments. “Our findings provide strong evidence for the global rollout of dolutegravir for childrenContinue Reading

WEDNESDAY, Dec. 22, 2021 (HealthDay News) — The U.S. Food and Drug Administration on Wednesday approved the emergency use of Pfizer’s new antiviral pill Paxlovid in people who are at high risk for severe COVID-19. It’s the first approved treatment for COVID-19 meant to be taken at home. “Today’s authorizationContinue Reading

WEDNESDAY, Dec. 22, 2021 (HealthDay News) — The U.S. Army says it has developed a COVID-19 vaccine it believes could work against any and all coronavirus variants, including Omicron. Results from early human trials of the Spike Ferritin Nanoparticle (SpFN) COVID vaccine are expected by the end of the month,Continue Reading